BHARAT BIOTECH
Covaxin Approval: WHO's Technical Advisory Group to Meet on October 26 on Emergency Use Listing for Bharat Biotech's COVID-19 Vaccine
WHO’s Emergency Use Authorisation for Bharat Biotech's Covaxin Further Delayed, Say Sources
COVID-19 Vaccine Must Not Be Entry Barrier for Nations, Says Bharat Biotech Co-Founder Suchitra Ella
US To Open For Fully Vaccinated Air Travellers In November, For Indians Only Covishield On Approved List
International Vaccine Institute and Bharat Biotech Launch Chikungunya Vaccine's Trial in Costa Rica
Bharat Biotech On COVID-19 Vaccine Covaxin Quality, Says 'Every Batch Goes Through Over 200 Tests'
COVID-19 Vaccine for Children: Bharat Biotech’s Covaxin Trials for Kids Currently Underway, Results Expected by September, Says Dr Randeep Guleria
COVID-19 Vaccine Update: Bharat Biotech's Partner Ocugen Seeks Approval for Covaxin in Canada
Covaxin COVID-19 Vaccine Shows 77.8% Overall Efficacy, 65.2% Protection Against Delta Variant, Claims Bharat Biotech in Results From Phase 3 Clinical Trials
Brazil to Suspend COVID-19 Vaccine Covaxin Deal with Bharat Biotech Over Allegations of Irregularities Against President Jair Bolsonaro
India Likely To Have COVID-19 Vaccine for Children Above 2 Years by September-October: AIIMS Director Dr Randeep Guleria
Google Trends